A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients

Clinical trial NCT02661100 · WITHDRAWN

Trial details

NCT number: NCT02661100
Sponsor: Case Comprehensive Cancer Center
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Advanced Triple Negative Breast Cancer Small Cell Lung Cancer Urothelial Cancer Mesothelioma Malignant Melanoma

Start date: 2017-01-01
Primary completion: 2018-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.